Psychedelic Nasal Spray Shakes Up Depression Care

Beckley’s new nasal spray, BPL-003, just crushed its Phase II trial for treatment-resistant depression—patients saw big improvements after just one dose, and the effects lasted nearly two months! The best part? Minimal side effects and no serious issues reported. This could be a game-changer for people who haven’t found relief with other treatments. Plus, Beckley’s merger with atai Life Sciences is now full steam ahead. Could psychedelics finally go mainstream for mental health? #Health #MentalHealth #Psychedelics